Gregory Marvell Net Worth

The estimated Net Worth of Gregory Marvell is at least $4.65 Million dollars as of 4 February 2011. Gregory Marvell owns over 40,078 units of Brooks Automation stock worth over $4,157,556 and over the last 15 years Gregory sold BRKS stock worth over $491,757.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Gregory Marvell BRKS stock SEC Form 4 insiders trading

Gregory has made over 1 trades of the Brooks Automation stock since 2011, according to the Form 4 filled with the SEC. Most recently Gregory sold 40,078 units of BRKS stock worth $491,757 on 4 February 2011.

The largest trade Gregory's ever made was selling 40,078 units of Brooks Automation stock on 4 February 2011 worth over $491,757. On average, Gregory trades about 8,016 units every 0 days since 2010. As of 4 February 2011 Gregory still owns at least 36,760 units of Brooks Automation stock.

You can see the complete history of Gregory Marvell stock trades at the bottom of the page.

What's Gregory Marvell's mailing address?

Gregory's mailing address filed with the SEC is C/O BROOKS AUTOMATION, INC., 15 ELIZABETH DRIVE, CHELMSFORD, MA, 08124.

Insiders trading at Brooks Automation

Over the last 21 years, insiders at Brooks Automation have traded over $110,337,278 worth of Brooks Automation stock and bought 84,885 units worth $755,883 . The most active insiders traders include Stephen S Schwartz, Amin J Khoury, and A Clinton Allen. On average, Brooks Automation executives and independent directors trade stock every 22 days with the average trade being worth of $1,392,261. The most recent stock trade was executed by David Jarzynka on 19 November 2021, trading 10,216 units of BRKS stock currently worth $1,228,883.

What does Brooks Automation do?

Brooks Automation Inc. is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world's leading semiconductor chip makers and equipment manufacturers. Brooks is headquartered in Chelmsford, MA, with operations in North America, Europeand Asia.

Complete history of Gregory Marvell stock trades at Brooks Automation

Brooks Automation executives and stock owners

Brooks Automation executives and other stock owners filed with the SEC include:

• Stephen Schwartz,
  President, Chief Executive Officer, Director
• Lindon Robertson,
  Chief Financial Officer, Executive Vice President
• Guojuan Liao,
  President - GENEWIZ
• David Jarzynka,
  President of Brooks Semiconductor Solutions Group
• Dr. Stephen S. Schwartz,
  CEO, Pres & Director
• David Gray,
  Senior Vice President, Chief Strategy and New Business Officer
• William Montone,
  Senior Vice President - Human Resources
• David E. Jarzynka,
  Pres of Semiconductor Solutions Group
• Dr. Guojuan Liao Ph.D.,
  Pres of Life Sciences Services
• Joseph Martin,
  Independent Chairman of the Board
• Ellen Zane,
  Independent Director
• Alfred Woollacott,
  Independent Director
• Krishna Palepu,
  Independent Director
• A. Clinton Allen,
  Independent Director
• Mark Wrighton,
  Independent Director
• Kirk Pond,
  Independent Director
• Robyn Davis,
  Independent Director
• Michael Rosenblatt,
  Independent Director
• Erica McLaughlin,
  Director
• Sherry Dinsmore,
  IR Contact Officer
• David Pietrantoni,
  Principal Accounting Officer, Vice President - Finance, Corporate Controller
• Jason Joseph,
  Senior Vice President, General Counsel, Secretary
• J. Robert Woodward,
  Sr. VP of Quality & Engineering
• William T. Montone,
  Sr. VP of HR
• John E. O'Brien,
  VP of Corp. Devel.
• Mark Namaroff,
  Director of Investor Relations
• David F. Pietrantoni,
  VP of Fin., Corp. Controller & Principal Accounting Officer
• John K Mcgillicuddy,
  Director
• Maurice H. Tenney,
  President-Brooks Life Sciences
• Sally White,
  SVP, Global Services
• Chong Sup Park,
  Director
• A. Michaud Steven,
  SVP, Critical Components Group
• John Lillig,
  SVP, MD, Brooks Life Sciences
• Marvin G Schorr,
  
• Gregory Marvell,
  VP, Extended Factory Group
• Robert Lepofsky,
  Director
• Shaun Wilson,
  VP, Global Customer Operations
• Thomas S Grilk,
  Sr. VP and General Counsel
• Ralf K Wuellner,
  President, Global Cust Op Grp
• Juergen Giessmann,
  Director
• Amin J Khoury,
  Director
• Charles M Mckenna,
  Executive VP
• Steven P Wentzell,
  SVP, Human Resources
• Jeffrey A Cassis,
  SVP, Global Sales and Service
• Santo Dinaro,
  SVP, Hardware Automation Group
• Peter Frasso,
  SVP Global Operations
• Roger D Emerick,
  Director
• Joseph Bellini,
  S.V.P. Software Group
• Robert J Therrien,
  PRESIDENT
• Investment Management Cod3 ...,
  
• Michael W Pippins,
  Sr VP Corporate Marketing
• Robert W Jr Woodbury,
  SVP and CFO
• Richard Small,
  VP Corporate Controller
• James Gentilcore,
  President & COO
• Robert E Anastasi,
  Executive Vice President
• Edward C Grady,
  President and COO
• Frank Casal,
  Director
• Mark D Morelli,
  EVP - Chief Operating Officer
• Martin S Headley,
  EVP & Chief Financial Officer
• Thomas Leitzke,
  SVP, Global Operations
• Kush Mirchandani,
  SVP, Worldwide Sales
• Timothy S Mathews,
  Principal Accounting Officer
• Clinton M. Haris,
  VP, Systems Solutions Group
• Robin Vacha,
  SVP, GM BLS-Products
• Jesus Linda De,
  Chief Commercial Officer, LS
• Kimberly Crowley,
  Chief Human Resources Officer